MIF - Mif macrophage migration inhibitory factor Gene

种属: Rattus norvegicus

基因 ID: 81683 | 基因类型: protein coding

关于 MIF

功能概要

Predicted to enable several functions, including identical protein binding activity; intramolecular oxidoreductase activity; and receptor ligand activity. Involved in several processes, including positive regulation of transport; response to steroid hormone; and response to vitamin. Located in cytoplasm; extracellular space; and nucleus. Used to study several diseases, including acute necrotizing pancreatitis; cardiomyopathy (multiple); lung disease (multiple); retinitis; and toxic shock syndrome. Biomarker of borna disease; cystitis; kidney disease; myocardial infarction; and type 2 diabetes mellitus. Human ortholog(s) of this gene implicated in allergic disease; asthma; cystic fibrosis; lung disease (multiple); and obesity. Orthologous to human MIF (macrophage migration inhibitory factor). [provided by Alliance of Genome Resources, Apr 2022]

MIF 基因产物(1)

mRNA	Protein	Name
NM_031051.2	NP_112313.1	macrophage migration inhibitory factor

基因本体论

分子功能
生物过程
细胞组分

分子功能 GO 注释	逻辑证据	参考文献	来源
enables protein-containing complex binding	IDA IDA: 通过直接分析推断	15947686	RGD

生物过程 GO 注释	逻辑证据	参考文献	来源
involved in brain renin-angiotensin system	IMP IMP: 通过突变表型推断	17261648	RGD
involved in cellular response to hydrogen peroxide	IEP IEP: 通过表达模式推断	19799867	RGD
involved in cellular response to hypoxia	IEP IEP: 通过表达模式推断	19462902	RGD
involved in drinking behavior	IMP IMP: 通过突变表型推断	16809436	RGD
involved in hair follicle development	IEP IEP: 通过表达模式推断	16232303	RGD
involved in positive regulation of D-glucose import	IMP IMP: 通过突变表型推断	11086030	RGD
involved in positive regulation of acute inflammatory response	IMP IMP: 通过突变表型推断	16455830	RGD
involved in positive regulation of axon regeneration	IMP IMP: 通过突变表型推断	12456989	RGD
involved in positive regulation of glycolytic process	IMP IMP: 通过突变表型推断	11086030	RGD
involved in positive regulation of immune response	IMP IMP: 通过突变表型推断	10617911	RGD
involved in positive regulation of potassium ion transport	IMP IMP: 通过突变表型推断	16267117	RGD
involved in positive regulation of smooth muscle cell migration	IMP IMP: 通过突变表型推断	18270460	RGD
involved in response to estradiol	IEP IEP: 通过表达模式推断	17324399	RGD
involved in response to glucocorticoid	IEP IEP: 通过表达模式推断	17565848	RGD
involved in response to hormone	IEP IEP: 通过表达模式推断	15196698	RGD
involved in response to insulin	IEP IEP: 通过表达模式推断	12435855	RGD
involved in response to lipopolysaccharide	IEP IEP: 通过表达模式推断	14980085	RGD
involved in response to mechanical stimulus	IEP IEP: 通过表达模式推断	15886670	RGD
involved in response to menaquinone	IEP IEP: 通过表达模式推断	15856362	RGD
involved in response to progesterone	IEP IEP: 通过表达模式推断	17324399	RGD
involved in response to vitamin E	IEP IEP: 通过表达模式推断	10609875	RGD
involved in response to xenobiotic stimulus	IEP IEP: 通过表达模式推断	16571782	RGD
involved in skin development	IEP IEP: 通过表达模式推断	16232303	RGD
involved in spermatogenesis	IMP IMP: 通过突变表型推断	15169922	RGD

细胞组分 GO 注释	逻辑证据	参考文献	来源
located in extracellular space	IDA IDA: 通过直接分析推断	15947686	RGD

EXP：通过实验结果推断 IDA：通过直接分析推断 IPI：通过物理相互作用推断 IMP：通过突变表型推断 IGI：通过遗传相互作用推断 IEP：通过表达模式推断

蛋白主名

其他名称

macrophage migration inhibitory factor

L-dopachrome isomerase	L-dopachrome tautomerase
glutathione-binding 13 kDa protein	macrophage migration inhibitory factor (glycosylation-inhibiting factor)
phenylpyruvate tautomerase

相关产品

Approval

生物活性分子 (1)

目录号	产品名	作用方式	纯度	是否罕见病
HY-17009	Iguratimod	Inhibitor	98.49%	是

Clinical Phase

生物活性分子 (2)

目录号	产品名	作用方式	纯度	Phase
HY-105077A	Nemifitide diTFA		98.24%	Phase 2
HY-16692	ISO-1	Inhibitor	99.94%	Phase 1

抗体抑制剂 (1)

目录号	产品名	作用方式	纯度	Phase
HY-P99262	Imalumab	Inhibitor	98.37%	Phase 2

Pre-clinical Phase

生物活性分子 (34)

Cat. No.	产品名	作用方式	纯度	是否罕见病
HY-110063	4-IPP	Inhibitor	99.46%	否
HY-147390	MIF098	Inhibitor	99.96%	否
HY-110095	(±)-CPSI-1306	Antagonist	99.64%	否
HY-107663A	MIF-1 TFA	Modulator	99.34%	否
HY-130332	Mitomycin A	Inhibitor	98.3%	否
HY-148117	MD13	Inhibitor	99.96%	否
HY-W019710	(E,E)-RGFP966	Inhibitor	99.31%	否
HY-110084	BTZO-1		99.32%	否
HY-123814	4-CPPC	Inhibitor	99.64%	否
HY-N10096	Epoxyazadiradione		99.24%	否
HY-W164560	RDR 03785	Inhibitor	96.24%	否
HY-D0039	3-Cyanoumbelliferone		≥98.0%	否
HY-149308	MKA031	Inhibitor	98.69%	否
HY-115887	R110	Inhibitor	99.90%	否
HY-RS12386	S100A9 Human Pre-designed siRNA Set A	Pre-designed Set	/	否
HY-107663	MIF-1	Modulator	/	否
HY-115888	MIF2-IN-1	Inhibitor	/	否
HY-144190	MIF-IN-1	Inhibitor	/	否
HY-144194	MIF-IN-2	Inhibitor	/	否
HY-144195	MIF-IN-3	Inhibitor	/	否
HY-144196	MIF-IN-4 hydrochloride	Inhibitor	/	否
HY-146318	MIF-IN-5	Inhibitor	/	否
HY-146319	MIF-IN-6	Inhibitor	/	否
HY-155466	Boc-MIF-1-Am	Activator	/	否
HY-P3087	Tyr-W-MIF-1	Modulator	/	否
HY-RS00653	AMH Human Pre-designed siRNA Set A	Pre-designed Set	/	否
HY-RS08445	MIF Human Pre-designed siRNA Set A	Pre-designed Set	/	否
HY-RS12385	S100A8 Human Pre-designed siRNA Set A	Pre-designed Set	/	否
HY-W415753	Alaptide		/	否
HY-173624	TE-11	Inhibitor	/	否
HY-174842	HTS05585	Inhibitor	/	否
HY-RS16522	Mif Mouse Pre-designed siRNA Set A	Pre-designed Set	/	否
HY-RS22953	Mif Rat Pre-designed siRNA Set A	Pre-designed Set	/	否
HY-U00271	Pareptide monohydrochloride		/	否

直系同源

种属	基因名	来源	基因 ID
Homo sapiens	MIF	NCBI	NCBI:4282
Canis familiaris	MIF	NCBI	NCBI:595146
Macaca fascicularis	MIF	NCBI	NCBI:101867092
Mus musculus	MIF	NCBI	NCBI:17319

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。	站点地图隐私声明
沪ICP备15051369号-4 上海工商沪公网安备31011502019417 沪(浦)应急管危经许[2021]201709(QFYS) 营业执照（三证合一）
Copyright © 2013-2025 MedChemExpress. All Rights Reserved.

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。

站点地图隐私声明

沪ICP备15051369号-4